Structure of State Regulatory Authorities REGISTRATION CERTIFICATE ISSUING AUTHORITY ROSZDRAVNADZOR
|
|
- Natalie Strickland
- 8 years ago
- Views:
Transcription
1 PRESENTATION REGISTRATION OF PHARMACEUTICAL PRODUCTS IN RUSSIA Alyona Chorich, Regulatory Affairs Manager PharmaReg, Moscow 1. Registration in Russia conception. Pharmaceutical products / food supplements /cosmetics different registration ways. To enter into Russian market all pharmaceutical products must be registered. Registration is a procedure of expertise of the pharmaceutical product quality, efficacy and safety by State Regulatory Authority. After such expertise it is issued Registration Certificate and the product is introduced in the database of registered products in Russian Federation. From 2008 Registration Certificate is unlimited. But before this date Registration Certificates were issued only for 5 years. A big number of already registered products must pass re-registration. Registration Certificate is the same document as Marketing Authorization. In Russia there are 2 strictly divided categories: pharmaceutical products (one category) and food supplements and cosmetics (another category). The product must be associated with one from these categories. It is absent such category as curative cosmetics. The registration expertise of these 2 categories differs very much. Pharmaceutical products pass more detailed and strict examination; need more documentation and additional expertise. The most import legislative acts about registration of pharmaceutical products are: - Medicines Act "Administrative Regulations of the Roszdravnadzor on execution of the state function of pharmaceutical products registration" approved by order of Ministry of Health and Social Development of Russian Federation No. 736 dated At the present moment it is under approval revised version of Medicines Act. 2. State Russian Regulatory Authorities (Roszdravnadzor, Rospotrebnadzor, National Center of Pharmaceutical Products Expertise (FGU), National Center of Nutrition) structure; interaction with applicants; differences in requirements for Russian and Foreigner Manufacturers. State Regulatory Authority is called Federal Service on Supervision in Sphere of Public Health Services and Social Development (Roszdravnadzor). Roszdravnadzor takes the decision to register the product and issues Registration Certificate. The expertise of all pharmaceutical products quality, efficacy and safety is done by National Center of Pharmaceutical Products Expertise (FGU). Only this National Center is authorized to execute independent expertise especially for Roszdravnadzor. According to new Medicines Act which is under approval additional Centers will be authorized to make registration expertise of pharmaceutical products. Structure of State Regulatory Authorities REGISTRATION CERTIFICATE ISSUING AUTHORITY ROSZDRAVNADZOR Department of pharmaceutical products registration
2 PHARMACEUTICAL PRODUCTS EFFICACY AND SAFETY EXPERTISE AUTHORITY National Center of Pharmaceutical Products Expertise (FGU) of Roszdravnadzor Section of coordination and data-base handling Institute of Products Quality Control Institute of Preclinical and Clinical Expertise Section of trade name expertise Quality Control Laboratory Specialized Commissions (bioequivalence, clinical, preclinical) National Center of Pharmaceutical Products Expertise consists from different Sections and Institutes. The biggest and the most important part of the registration procedure pass in the mentioned Center. Applicants for products registration submit registration documents directly to National Center. The registration procedure is organized in the way that regulatory affairs specials must communicate with experts every week. It is fixed the schedule of visiting days. Terms of registration depend a lot from the correctly organized work of the regulatory affairs specialist. The registration procedure is the same for Russian and Foreigner manufacturers. Differences appear in cost and documents. Also the important fact is that foreigner manufacturer must have GMP-certificate. The product is not necessary to be registered in the country of origin or another country. It is admitted to apply for registration products which will be authorized only in Russian Federation. State Regulatory Authorities are situated only in Moscow. There are absent divisions in other regions on Russian Federation. 3. Registration file list of documents, comparison of European and Russian registration files. Who can be the Applicant for registration, Marketing Authorization holder, Manufacturer? Official docs issued by Foreigner State Authorities legalization for Russia. Registration file (or dossier) represents the documents submitted to State Regulatory Authority for registration. Russian registration file consists from 6 parts: Administrative documents Description of pharmaceutical properties Data about manufacturing of pharmaceutical product Data about quality control of the finished pharmaceutical product Data about PRE-CLINICAL pharmacological and toxicological studies of pharmaceutical product Data about CLINICAL studies of pharmaceutical product European registration file consists from 5 modules. The structure of Russian and European registration files is very similar. If manufacturer has European registration file it is not necessary to prepare separated docs for Russia. All data required for Russian dossier are available in European file. Russian registration file must be presented to State Regulatory Authorities in Russian language.
3 In the Registration Certificate there are mentioned the following participants in Manufacturing process: Marketing Authorization Holder Manufacturer of the finished product Primary packaging Secondary packaging Batch release site On each of the above mentioned manufacturing stage can be indicated 2 companies. And also all of these stages can be represented by different companies. The important is to submit the contract agreement between all participants. The applicant for registration can be: Marketing Authorization Holder or its Representation in Russia Physical person Russian juridical company (third party) The rights to represent the interests of marketing Authorization Holder must confirmed by legalized Power of attorney. Thus it is not necessary to open Representation of the company in Russia especially to register pharmaceutical products. It is possible to register the products and after that to begin the business activity. Official documents such as Certificate of Pharmaceutical Product, GMP-certificate, Manufacturing License, Power of Attorney must be legalized. If the state of official documents issue is a State- Member of Hague Convention such documents must be apostilled. If not the documents must be legalized by Russian Embassy. 4. Registration of original and generic pharmaceutical products stages, terms and cost. Registration process conditionally can be divided into 3 basic stages Scheme of registration process Compiling of Registration dossier in Russian and its submission to the National Center of Pharmaceutical Products Expertise (FGU). I stage Expertise of the pharmaceutical product Quality, Efficacy and Safety in the National Center of Pharmaceutical Products Expertise (FGU). II stage Institute of Products Quality Control Quality Control Expertise Institute of Preclinical and Clinical Expertise Efficacy and Safety Expertise Finishing of the expertise and submission of the dossier to Roszdravnadzor for issuing of Registration Certificate. III stage At I stage of registration process it is necessary to collect all necessary documents, to translate them into Russian and to compile registration dossier.
4 The most difficult and longest is the II stage. Registration dossier after submission and payment of necessaries fees is directed to appointed experts from Institute of Products Quality Control and Institute of Preclinical and Clinical Expertise. In the Institute of Products Quality Control it is done the verification of Finished Product Specification called in Russian Normative Document and also is performed the laboratory control. In the Institute of Preclinical and Clinical Expertise it is checked the Instruction for administration. In case if necessity of preclinical or clinical tests the product is directed to specialized Research Institute. Original and generic products pass the same stages of registration. Original products must pass through all registration procedures while the generic products are exempted from some of them. For example for original product must conducted clinical trials in Russia. For generic products can be conducted only bioequivalence studies and not only in Russia. Preclinical and clinical studies performed in foreigner countries are accepted. Terms of registration process: I stage + II stage + III stage 2 months 12 months 4 months = TOTAL 18 months The time of registration can be increased in the following cases: The necessity to carry out of additional preclinical and clinical trials The necessity to carry out of repeated laboratory quality control. Delay of granting of additional required data by State Regulatory Authority more than 30 days. COST OF REGISTRATION The cost of registration of one pharmaceutical product consists from 2 parts: Official payments to State Authorities + payment of regulatory affairs specialist or company services = approx $ $ = approx $ approx approx $ = approx $ OFFICIAL PAYMENTS paid to State Authority (National Center of Pharmaceutical Products Expertise (FGU)) for one pharmaceutical product registration for foreigner manufacturers are the following: Name of procedure Cost, $ Cost, Note Examination of documents (one registration dossier) $ The whole sum must be paid at the beginning of the registration process. The registration expertise will not begin until the customer will not pay the invoice.
5 Laboratory quality expertise $ TOTAL $ The cost of Laboratory quality expertise depends on the number of dosages and the analytical methods used. 5. Laboratory Control of pharmaceutical products during registration and post-registration Control at the stage of import for selling (essential moments, possible difficulties). During registration process all products must pass laboratory control according to approved Normative Document. Possible difficulties are: necessary of introduction in finished product specification of additional tests, importing of standards and samples. Normative Document in Russia is compiled according to manufacturer s finished product specification, European/British Pharmacopoeia, United States Pharmacopoeia and Russian Pharmacopoeia. To import the samples and standards for laboratory control it is necessary to receive special Import permission from Roszdravnadzor. It takes 1-2 months and prolonged the time of registration. The full analysis of the pharmaceutical product is done on the stage of registration and on the first 3 batched imported into Russian market for selling. The time of laboratory control is 4 months, plus 2 months to import necessary standards. It is necessary to take in consideration that within this time (6 months) the product will be holed at the custom. 6. Post-Registration Variations types, documents, terms. The result of registration process is obtaining of Registration Certificate. Along with it are given Normative Document, Instruction for administration and Colored design of packaging. All these documents are signed by representative of the License Authorization (Registration Certificate) Holder and approved by Roszdravnadzor. Any changes introduced in these documents must be approved by State Regulatory Authority as Variation. There are 2 types of Variations: Type Classification Examples Variation type I Don t need Quality, Efficacy or Safety expertise Variation type II Need Quality, Efficacy or Safety expertise Change of the Manufacturer s name; Change of Marketing Authorization holder; Change of package design Change of manufacturing site; change of quality or quantity composition; change of instruction for administration Terms of variation approval: Type Variation type I Variation type II Terms 2-3 months 6-12 months
Importing pharmaceutical products to China
Importing pharmaceutical products to China Imported pharmaceutical products need pre-market approval before entering the Chinese market Imported drugs for human use are required to obtain pre-market approval
More informationSPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT
SPECIFICATIONS AND CONTROL TESTS ON THE FINISHED PRODUCT Guideline Title Specifications and Control Tests on the Finished Product Legislative basis Directive 75/318/EEC as amended Date of first adoption
More informationEXPERT REVIEW PANEL PROCEDURE: ADDITIONAL SUPPORT TO PROCUREMENT AGENCIES UNDER EXCEPTIONAL CIRCUMSTANCES
EXPERT REVIEW PANEL PROCEDURE: ADDITIONAL SUPPORT TO PROCUREMENT AGENCIES UNDER EXCEPTIONAL CIRCUMSTANCES Introduction The WHO Prequalification of Medicines Programme (PQP) was established to provide UN
More informationComparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE
Comparative analysis between the possible regulatory approaches to GMP compliance TITOLO PRESENTAZIONE Dr. Fulvio CARLOTTI, GNOSIS SpA, Corporate QA Director September 26, 2014 Scope of GMP GMP compliance
More informationSession 6: WHO Prequalification Programme. Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs
Session 6: WHO Prequalification Programme Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs Session adapted from the WHO training workshop on prequalification and the WHO technical briefing seminar
More informationMINISTRY OF HEALTH OF THE RUSSIAN FEDERATION. ORDER 737n October 14, 2013
Registered with the Ministry of Justice of Russia on June 20, 2014, 32823 MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION ORDER 737n October 14, 2013 ON THE APPROVAL OF THE ADMINISTRATIVE REGULATIONS OF THE
More informationCHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS
CHAPTER 6 PROCUREMENT AND SUPPLY OF PHARMACEUTICAL PRODUCTS IN THE PUBLIC AND PRIVATE MEDICAL SECTORS Overview 6.1 This chapter sets out the Review Committee s findings and recommendations on procurement
More informationWorking Party on Control of Medicines and Inspections. Final Version of Annex 16 to the EU Guide to Good Manufacturing Practice
Version 8 (final) EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, regulatory environment, industries under vertical legislation Pharmaceuticals and cosmetics Brussels, July 2001 S\common\legal-legislation\75-319nd81-851\91-356\eudralexvol4\Annex
More informationFRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT
FRENCH AGENCY FOR VETERINARY MEDICINAL PRODUCTS DECENTRALISED PROCEDURE FOR A VETERINARY MEDICINAL PRODUCT VIRBAKOR 20 mg film-coated tablet for dogs Date: 03/11/2014 French agency for food, environnemental
More informationOfficial Journal of the European Union. (Acts whose publication is obligatory)
27.12.2006 L 378/1 I (Acts whose publication is obligatory) REGULATION (EC) No 1901/2006 OF THE EUROPEAN PARLIAMT AND OF THE COUNCIL of 12 December 2006 on medicinal products for paediatric use and amending
More informationGOVERNMENT OF THE RUSSIAN FEDERATION RESOLUTION from December 27, 2012 N 1416 APPROVAL OF THE RULES STATE REGISTRATION OF MEDICAL PRODUCTS
GOVERNMENT OF THE RUSSIAN FEDERATION RESOLUTION from December 27, 2012 N 1416 APPROVAL OF THE RULES STATE REGISTRATION OF MEDICAL PRODUCTS In accordance with Article 38 of the Federal Law "On the basis
More informationIntroduction to the CTA & NDA process in China
Introduction to the CTA & NDA process in China Jie Zhang, Regulatory Affairs, Abbott China Presented by: Peter van Amsterdam, Clinical Pharmacology & Bioanalytics, Abbott Netherlands EBF/CBF China Days,
More information2014 Annual Report on Inspections of Establishments
2014 Annual Report on Inspections of Establishments Table of Contents Introduction... 2 Data Collection and Definitions... 3 Section 510(h)(6)(A)(i) Number of Domestic and Foreign Establishments Registered
More informationPart 3 Medical Officer (MO) Work Level Standards
Part 3 Medical Officer (MO) Work Level Standards MEDICAL OFFICER-CLASSES 1 6 GROUP STANDARD The work of positions in this group involves the application of professional medical knowledge and experience
More informationSchool of Pharmacy TEMPLE UNIVERSITY
School of Pharmacy TEMPLE UNIVERSITY Regulatory Affairs and Quality Assurance Graduate Program Te mple Unive rsity School of Pharmacy Re gulatory Affairs and Quality Assurance Graduate Program 4 25 Comme
More informationWales Patient Access Scheme: Process Guidance
Wales Patient Access Scheme: Process Guidance July 2012 (Updated September 2014) This guidance document has been prepared by the Patient Access Scheme Wales Group, with support from the All Wales Therapeutics
More informationSADC GUIDELINES ON IMPORT AND EXPORT PROCEDURES FOR PHARMACEUTICAL PRODUCTS
SADC GUIDELINES ON IMPORT AND EXPORT PROCEDURES FOR PHARMACEUTICAL PRODUCTS June 2006 1 INTRODUCTION Public health concerns demand that the manufacture of pharmaceutical products and their subsequent handling
More informationGuide to Fees for Veterinary Products
Guide to Fees for Veterinary Products FIN-G0003-14 04 FEBRUARY 2016 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS ABBREVIATIONS
More informationMedical Device Regulatory Requirements for Taiwan
Medical Device Regulatory Requirements for Taiwan Disclaimer: The information contained on this website is derived from public sources and is current to the best of the knowledge of the Department of Commerce
More informationMarketing Authorisation Of A Product In Czech Republic
MARKETING AUTHORISATION APPLICATION FOR NEW PLANT PROTECTION PRODUCTS VIA THE MUTUAL RECOGNITION PROCEDURE AS SPECIFIED UNDER REGULATION (EC) No 1107/2009 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL
More informationAuthorisation and Restriction Newsletter
Authorisation and Restriction Newsletter August 2010, N 1 The information contained in this document is intended for guidance only and whilst the information is provided in utmost good faith and has been
More informationINFORMATION TECHNOLOGIES FOR PATIENT CARE MANAGEMENT
SUMMARY Features INTERIN Technology, a complex of software tools and techniques for building health care information systems, was developed in the Program Systems Institute, Russian Academy of Sciences.
More informationMasters Learning mode (Форма обучения)
Program Title (Название программы): Pharmacology Degree (Степень) Masters Learning mode (Форма обучения) Full-time and part-time Duration of study (Продолжительность программы) 2 years (4 years part time)
More informationCollege ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board. Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands
College ter Beoordeling van Geneesmiddelen / Medicines Evaluation Board Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY
More informationUnedited version adopted by the 45th WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organization 2010
GUIDELINE ON SUBMISSION OF DOCUMENTATION FOR A MULTISOURCE (GENERIC) FINISHED PHARMACEUTICAL PRODUCT (FPP): PREPARATION OF PRODUCT DOSSIERS (PDS) IN COMMON TECHNICAL DOCUMENT (CTD) FORMAT Unedited version
More informationRAPS ONLINE UNIVERSITY
RAPS ONLINE UNIVERSITY Practical education and training for business success. For regulatory professionals, there is only one name to know and trust for online education and training RAPS Online University.
More informationAgreement. Double Degree Master s Program. International Relations. Between
Agreement Double Degree Master s Program in International Relations Between Federal State Educational Budgetary Institution of Higher Professional Education Moscow State Institute of International Relations
More informationREGULATORY OVERVIEW DISTRIBUTION OF PHARMACEUTICAL PRODUCTS
REGULATORY FRAMEWORK Our products are subject to regulatory controls governing pharmaceutical products and medical appliances and equipment. Thus we are subject to regulation and oversight by different
More informationBUSINESS REGISTRATION HANDBOOK LIMITED LIABILITY WITH ONE MEMBERS
STATE SECRETARIAT FOR ECONOMIC AFFAIRS AGENCY FOR BUSINESS REGISTRATION UNITED NATIONS INDUSTRIAL DEVELOPMENT ORGANIZATION BUSINESS REGISTRATION HANDBOOK LIMITED LIABILITY WITH ONE MEMBERS PROJECT TECHNICAL
More informationThe 505(b)(2) Drug Development Pathway:
The 505(b)(2) Drug Development Pathway: When and How to Take Advantage of a Unique American Regulatory Pathway By Mukesh Kumar, PhD, RAC and Hemant Jethwani, MS The 505(b)(2) regulation offers a less expensive
More informationKazan (Volga region) Federal University, Kazan, Russia Institute of Fundamental Medicine and Biology. Master s program.
Kazan (Volga region) Federal University, Kazan, Russia Institute of Fundamental Medicine and Biology Master s program Bioinformatics I. THEORETICAL BASIS The development of effective technologies of theoretical
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)
European Medicines Agency Inspections London, 19 May 2005 CPMP/QWP/4359/03 EMEA/CVMP/205/04 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)
More informationNRA FUNCTION IN CONTROLLING VACCINES IN CLINICAL TRIAL AND MARKETING AUTHORIZATION INDONESIA 2013 DVI MEETING 9 11 APRIL 2013 1
NRA FUNCTION IN CONTROLLING VACCINES IN CLINICAL TRIAL AND MARKETING AUTHORIZATION INDONESIA 2013 DVI MEETING 9 11 APRIL 2013 1 2 The National Agency of Drug and Food Control (NA-DFC) is a non departmental
More informationREGULATION (EEC) No 2309/93
REGULATION (EEC) No 2309/93 Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use
More informationRisk Management Plan (RMP) Guidance (Draft)
Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Translated by Pharmaceuticals and Medical Devices Agency Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour
More informationPOST-MASTER S CERTIFICATES in ADVANCED QUALITY ASSURANCE or REGULATORY AFFAIRS
Temple University - School of Pharmacy 425 Commerce Drive, Suite 175 Fort Washington, PA 19034 Phone: 267.468.8560 Fax: 267.468.8565 POST-MASTER S CERTIFICATES in ADVANCED QUALITY ASSURANCE or REGULATORY
More informationEUROPEAN INDUSTRIAL PHARMACISTS GROUP
EUROPEAN INDUSTRIAL PHARMACISTS GROUP Guide to Good Regulatory Practice Acknowledgments: Valérie LACAMOIRE, Conseil Central de la section B de l Ordre des Pharmaciens Kelsey MOWER, Industrial Pharmacists
More informationEUROPASS DIPLOMA SUPPLEMENT
EUROPASS DIPLOMA SUPPLEMENT TITLE OF THE DIPLOMA (ES) Técnico Superior en Gestión de Ventas y Espacios Comerciales TRANSLATED TITLE OF THE DIPLOMA (EN) (1) Higher Technician in Sales Management and Commercial
More informationThe EFGCP Report on The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Russia
The Procedure for the Ethical Review of Protocols for Clinical Research Projects in Europe (Update: April 2011) Russia Question 1: What laws or regulations apply to an application for conducting a clinical
More informationPublic Assessment Report. Scientific discussion. Calcium and Vitamine D3 Alpex 1000 mg/880 IE, effervescent granules
Public Assessment Report Scientific discussion Calcium and Vitamine D3 Alpex 1000 mg/880 IE, effervescent granules (calcium carbonate and cholecalciferol) NL License RVG: 111783 Date: 12 March 2015 This
More informationLAW ON MEDICINES. Article 1. Article 2. Article 3 Manufacturing and marketing of medical devices is the activity of public interest.
LAW ON MEDICINES I BASIC PROVISIONS Article 1 This Law regulates conditions for manufacturing and marketing medicines for human use and use in veterinary medicine, measures for quality assurance, safety
More informationLegal Newsletter Optimization plan for legal entities and individual entrepreneurs registration procedures. Bulletin, May 2013
Legal Newsletter Optimization plan for legal entities and individual entrepreneurs registration procedures Bulletin, May 2013 Legal newsletter Optimization plan for legal entities and individual entrepreneurs
More informationQualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015
Qualified Persons in the Pharmaceutical Industry Code of Practice 2009, updated August 2015 *QP Code of Practice 2008 updated Aug15 Page 1 of 13 Code of Practice for Qualified Persons 1. INTRODUCTION 2.
More informationDrug Distribution Management Policy in Korea
Drug Distribution Management Policy in Korea Regarding introduction of Drug Serial Number System (Serialization) Ministry of Health and Welfare Drug Distribution Management Policy Overview Policy Objectives
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL VERSION 4.1
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Health systems and products Medicinal products quality, safety and efficacy Brussels, SANCO/D/6/SF/mg/ddg1.d.6(2013) IMPORTATION OF ACTIVE SUBSTANCES
More informationEUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY VERSION 7
EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY Health systems and products Medicinal products quality, safety and efficacy Brussels, IMPORTATION OF ACTIVE SUBSTANCES FOR MEDICINAL PRODUCTS
More informationHypromellose Eye Drops BP 0.3% w/v PL 23097/0006
Hypromellose Eye Drops BP 0.3% w/v PL 23097/0006 UKPAR TABLE OF CONTENTS Lay summary Page 2 Scientific discussion Page 3 Steps taken for assessment Page 9 Summary of product characteristics Page 10 Patient
More informationHaving regard to the Treaty establishing the European Economic Community, and in particular Article 100 thereof;
DIRECTIVE 65/65/EEC Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products (OJ L No 22 of
More informationExternal User Manual. Portal for Submission of Applications for the Update of the Manufacturing Flowchart as registered in INFARMED I.P.
Portal for Submission of Applications for the Update of the Manufacturing Flowchart as registered in INFARMED I.P. database Page 1 of 20 Index 1 General information... 3 2 Using the portal... 4 2.1 First
More informationGUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.
15 January 2007 GUIDELINE ON ACTIVE PHARMACEUTICAL INGREDIENT MASTER FILE (APIMF) PROCEDURE 1 (The APIMF procedure guideline does not apply to biological APIs.) TABLE OF CONTENTS 1 INTRODUCTION... 2 2
More informationGLOBAL EDUCATION PROGRAM
GLOBAL EDUCATION PROGRAM RUSSIAN FEDERATION GOVERNMENT-SPONSORED PROGRAM THAT OFFERS RUSSIAN CITIZENS AN OPPORTUNITY TO STUDY AT LEADING FOREIGN UNIVERSITIES REGULATIONS: ABOUT GEP http://educationglobal.ru/o_programme/
More informationEUROPASS DIPLOMA SUPPLEMENT
EUROPASS DIPLOMA SUPPLEMENT TITLE OF THE DIPLOMA (ES) Técnico Superior en Estética Integral y Bienestar TRANSLATED TITLE OF THE DIPLOMA (EN) (1) Higher Technician in Integral Aesthetics and Wellness ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
More informationDraft guidance for registered pharmacies preparing unlicensed medicines
Draft guidance for registered pharmacies preparing unlicensed medicines January 2014 1 The General Pharmaceutical Council is the regulator for pharmacists, pharmacy technicians and registered pharmacies
More informationZambia UK Health Workforce Alliance & Zambia Ministry of Health Conference
Zambia UK Health Workforce Alliance & Zambia Ministry of Health Conference CURRENT HEALTH BILLS/ACTS & RESTRUCTURING OF THE ZAMBIAN HEALTH SERVICE WITHIN MINISTRIES Maynard Theatre, The Kings Fund, 11
More informationMed-Info Regular Information Bulletins for the Medical Device Industry
Med-Info Regular Information Bulletins for the Medical Device Industry Product Service Globalization of Medical Device Approval Mutual Recognition Agreements (MRA) between the EU and the USA and Australia
More informationVolume 2B Notice to Applicants. Medicinal products for human use. Presentation and format of the dossier. Common Technical Document (CTD)
Volume 2B Notice to Applicants Medicinal products for human use Presentation and format of the dossier Common Technical Document (CTD) Introduction Edition June 26 Module 1 Edition May 28 Module 2 Edition
More informationCTD Dossier Preparation. Sr.Manager-Regulatory Affairs
CTD Dossier Preparation K. Srikantha Reddy Sr.Manager-Regulatory Affairs Medreich Limited Srikanth.k@medreich.com CTD Dossier Preparation CTD (Common Technical Document) contains 5 modules Module 1 Module
More informationGuideline on good pharmacovigilance practices (GVP)
1 2 20 February 2012 EMA/541760/2011 3 4 Guideline on good pharmacovigilance practices (GVP) Module I Pharmacovigilance systems and their quality systems Draft finalised by the Agency in collaboration
More informationA clinical research organization
A clinical research organization About Us State of art facility. All clinical trials carried out in accordance with ICH GCP guidelines. Quality services within stipulated time period. Team of experienced
More informationREACH-like regulations around the world. Dr. Adriana Jalba Manager, International Chemicals Management (ICM) Cefic
REACH-like regulations around the world Dr. Adriana Jalba Manager, International Chemicals Management (ICM) Cefic Content Global trends and issues of concern Concept of recent REACH-like chemical control
More informationEU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE
EU DIRECTIVE ON GOOD CLINICAL PRACTICE IN CLINICAL TRIALS DH & MHRA BRIEFING NOTE Purpose 1. The Clinical Trials Directive 2001/20/EC heralds certain additional responsibilities for the Medicines and Healthcare
More informationThe Clinical Trials Directive in the EU: Present and Future Elisabethann Wright, Partner Maurits Lugard, Partner. May 2010
The Clinical Trials Directive in the EU: Present and Future Elisabethann Wright, Partner Maurits Lugard, Partner May 2010 Background (1) The Clinical Trials Directive 2001/20/EC The intention of this Directive
More informationTHE BIOTECH & PHARMACEUTICAL INDUSTRY
THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues
More informationForeign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan
Islamic Republic of Afghanistan Ministry of Public Health General Directorate of Pharmaceutical Affairs Foreign Pharmaceutical Manufacturing Company Registration Guideline for Afghanistan 2015 Islamic
More informationCATEGORIES OF APPLICANTS AND DURATION OF SCHOLARSHIP
ANNOUNCEMENT OAS-China Scholarships The purpose of the Scholarship and Training Programs of the Organization of American States (OAS) is to help the Member States in their efforts to achieve their objectives
More informationNational Certificate in Pharmacy (Technician) (Level 5) with strands in Community, and Hospital Level 5
NZQF NQ Ref 0423 Version 7 Page 1 of 8 National Certificate in Pharmacy (Technician) (Level 5) with strands in Community, and Hospital Level 5 Credits 131 or 139 This qualification has been reviewed. The
More informationCollege ter Beoordeling van Geneesmiddelen (CBG) Medicines Evaluation Board (MEB) Graadt van Roggenweg 500 3531 AH Utrecht The Netherlands
MEB agency / Veterinary Medicinal Products Unit The Netherlands C B G M E B College ter Beoordeling van Geneesmiddelen (CBG) Medicines Evaluation Board (MEB) Graadt van Roggenweg 500 3531 AH Utrecht The
More informationInformation Letter. of Open Joint Stock Company RN Holding
Translation from Russian Information Letter of Open Joint Stock Company RN Holding Dear Shareholder, We hereby inform you that on November 6, 2013, Open Joint Stock Company RN Holding (hereinafter, the
More informationTHE CENTRAL BANK OF ARMENIA BOARD RESOLUTION
THE CENTRAL BANK OF ARMENIA BOARD RESOLUTION Approval of Regulation 16 Licensing of Money Transfer Organizations; Registration of Branches; Manager Qualification By virtue of Armenian Law on Licensing,
More informationGuideline on dossier requirements for Type IA and IB notifications
Guideline on dossier requirements for Type IA and IB notifications In accordance with Regulation (EC) No 726/2004 and Directives 2001/83/EC and 2001/82/EC, a common approach to the procedures for variations
More informationREGULATIONS FOR THE DEGREE OF BACHELOR OF PHARMACY IN CHINESE MEDICINE [PART-TIME] (BPharm[ChinMed])
REGULATIONS FOR THE DEGREE OF BACHELOR OF PHARMACY IN CHINESE MEDICINE [PART-TIME] (BPharm[ChinMed]) These regulations apply to students admitted to the first year of study in and after the academic year
More informationTRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP
DISCLAIMER: The EU reserves the right to make subsequent modifications to this text and to complement its proposals at a later stage, by modifying, supplementing or withdrawing all, or any part, at any
More informationCosmetic products in China
Cosmetic products in China Imported cosmetics need pre-market approval before entering China All cosmetics imported into China are required to obtain pre-market approval or notification from the Chinese
More informationAgencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio 8 28022 Madrid España (Reference Member State)
DEPARTAMENTO DE MEDICAMENTOS VETERINARIOS Medicamentos y Productos C/Campezo 1, Edificio 8 28022 Madrid España (Reference Member State) DECENTRALISED PROCEDURE [DRAFT] PUBLICLY AVAILABLE ASSESSMENT REPORT
More informationAh-Reum Seo of Chemservice Asia introduces the forthcoming chemicals regulation for South Korea
Environment & Regulations The best strategy to implement K-REACH Ah-Reum Seo of Chemservice Asia introduces the forthcoming chemicals regulation for South Korea Most existing chemicals on the market have
More informationMINISTER OF HEALTH. No: 4012/2003/QD BYT SOCIALIST REPUBLIC OF VIETNAM Independence Freedom Happiness Hanoi, 30 May 2007 2003 DECISION
MINISTRY OF HEALTH No: 4012/2003/QD BYT SOCIALIST REPUBLIC OF VIETNAM Independence Freedom Happiness Hanoi, 30 May 2007 2003 DECISION MINISTER OF HEALTH Promulgating regulations on registration of vaccines,
More informationDECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT
Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) Parque Empresarial Las Mercedes Edificio 8 C/ Campezo, 1 E - 28022 Madrid Spain (Reference Member State) DECENTRALISED PROCEDURE PUBLICLY
More informationThe Medical Device Industry in Korea: Strategies for Market Entry
The Industry in Korea: Strategies Seth J. Goldenberg, Senior Principal Scientist, NAMSA; Yongha Na, Director, Medipert Regulatory NAMSA Whitepaper #09 06/2014 Seth J. Goldenberg, PhD (sgoldenberg@namsa.com)
More informationm 4 Biobank Alliance & m 4 Trial Service Center
m 4 Biobank Alliance & m 4 Trial Service Center Services & Consulting in (non-)clinical development www.m4.de m 4 Biobank Alliance Central Access to High Quality Human Biospecimens for R&D The m 4 Biobank
More informationQUALITY, SAFETY AND EFICACY ASSESSOR
Curriculum vitae PERSONAL INFORMATION Javier Alonso Naveda WORK EXPERIENCE March 2014 Present SUPPORT CVMP MEMBER, CENTRALIZED MANAGEMENT PROCEDURES, REFERRALS, QRD, QUALITY ASSESSOR Support to the CVMP
More informationWhat is a Lasting Power of Attorney?
What is a Lasting Power of Attorney? A Lasting Power of Attorney is a legal document that you (the Donor) can make which allows you to choose someone now (the Attorney) that you trust to make decisions
More informationSubject SA2 Life Insurance Specialist Applications Syllabus
Subject SA2 Life Insurance Specialist Applications Syllabus for the 2015 exams 1 June 2014 Aim The aim of the Life Insurance Specialist Applications subject is to instil in the successful candidates the
More informationACADEMIC REGULATIONS FOR EHEA MASTER'S DEGREE COURSES AT THE UPC 2010-2011 ACADEMIC YEAR
ACADEMIC REGULATIONS FOR EHEA MASTER'S DEGREE COURSES AT THE UPC 2010-2011 ACADEMIC YEAR Office of the Vice-President for Academic Policy June 2010 Table of contents Introduction... 4 1. Master s degree
More informationBachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements
Bachelor of Science in Pharmaceutical Sciences (BSPS) Program Overview and Internship Requirements Pharmaceutical Sciences Applied sciences that underlie the practice of pharmacy the development, manufacture,
More informationPromoting innovation and improving access
NATIONAL ASSESSMENT TOOL TO ASSIST MEMBER STATES IN IMPLEMENTING THE GLOBAL STRATEGY AND PLAN OF ACTION ON PUBLIC HEALTH, INNOVATION AND INTELLECTUAL PROPERTY Promoting innovation and improving access
More informationНague Convention. on the Civil Aspects of International Child Abduction and its application in Russia. Every child has the right
Every child has the right to communicate with BOTH of its parents! Ministry of Education and Science of Russian Federation Department of State policy of children s rights protection Central Authority on
More informationADMISSIONS. Qualification required
ADMISSIONS Entry Requirements for Official Master s Degrees according to Royal Decree 1393/2007 Qualification required Notes 1. Spanish official university qualification. (three-year and four year Bachelor
More informationSenate Regulation 6: Regulations governing taught postgraduate programmes of study
Senate Regulation 6: Regulations governing taught postgraduate programmes of study 6.1 These regulations apply to all taught postgraduate programmes and students. 6.2 Senate may approve programmes which
More informationAnnex 3 Procedure for prequalification of pharmaceutical products
World Health Organization WHO Technical Report Series, No. 953, 2009 Annex 3 Procedure for prequalification of pharmaceutical products 1. Introduction 2. Glossary 3. Purpose and principles 4. Steps of
More informationThe Postgraduate Course Toxicology Vienna
The Postgraduate Course Toxicology Vienna Completion as Master of Science (Toxicology) Beginning of next course: Summer term 2016 OPEN FOR REGISTRATION AT ANY TIME Contents: History Objectives Participants
More informationSomulose, 400 mg/25 mg/ml, Avlivningsvätska för djur Secobarbital Sodium. Applicant: Dechra Limited
NATIONAL PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT Somulose, 400 mg/25 mg/ml, Avlivningsvätska för djur Secobarbital Sodium Applicant: Dechra Limited Postadress/Postal
More informationThe most frequently asked questions about the Global Education program
The most frequently asked questions about the Global Education program Contents The next steps... 3 What are the next steps? How long will it take to create the working infrastructure for the program?
More informationClinical Study Startup Timelines in Central and Eastern Europe
Vol. 11, No. 10, October 2015 Happy Trials to You Clinical Study Startup Timelines in Central and Eastern Europe By Vlad Bogin The complexity of regulatory approval pathways and time to first-site initiation
More informationSubject SA2 Life Insurance Specialist Applications. Syllabus. for the 2013 Examinations. Institute and Faculty of Actuaries.
Subject SA2 Life Insurance Specialist Applications Syllabus for the 2013 Examinations 1 June 2012 Institute and Faculty of Actuaries Aim The aim of the Life Insurance Specialist Applications subject is
More informationEVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS ON TABLET FRIABILITY GENERAL CHAPTER Q4B ANNEX 9(R1)
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL
More informationOverview. Health Science Authority. Implementation of ICH guideline in Singapore. Singapore s experience
ICH and Singapore Dr Christina Lim Deputy Group Director, Health Product Regulation Group Senior Advisor, International Collaboration Health Sciences Authority Singapore November 2008 Overview Health Science
More informationEUROPASS DIPLOMA SUPPLEMENT
EUROPASS DIPLOMA SUPPLEMENT TITLE OF THE DIPLOMA (ES) Técnico Superior en Comercio Internacional TRANSLATED TITLE OF THE DIPLOMA (EN) (1) Higher Technician in International Trade ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
More informationVOLUME 6A Procedures for marketing authorisation
EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 29.01.2007 ENTR/F2/KK D(2007) Revision 3.1 NOTICE TO APPLICANTS VETERINARY MEDICINAL PRODUCTS VOLUME
More informationCTC Technology Readiness Levels
CTC Technology Readiness Levels Readiness: Software Development (Adapted from CECOM s Software Technology Readiness Levels) Level 1: Basic principles observed and reported. Lowest level of software readiness.
More information